Xtx Topco LTD Precision Biosciences Inc Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.29 - $0.45 $3,541 - $5,495	12,212 New	12,212 $4,000
Q4 2022 Feb 14, 2023	SELL	$0.97 - $45.0 $83,859 - $3.89 Million	-86,453 Reduced 50.84%	83,585 $99,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $40.8 $107,630 - $3.6 Million	88,222 Added 107.83%	170,038 $221,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $67,429 - $195,837	58,634 Added 252.93%	81,816 $131,000
Q1 2022 May 13, 2022	BUY	$2.96 - $7.76 $68,618 - $179,892	23,182 New	23,182 $71,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.